A detailed history of Td Asset Management Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 88,600 shares of CABA stock, worth $165,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,600
Previous 134,030 33.9%
Holding current value
$165,682
Previous $1 Million 58.28%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$3.94 - $8.24 $178,994 - $374,343
-45,430 Reduced 33.9%
88,600 $418,000
Q2 2024

Aug 02, 2024

BUY
$7.22 - $18.82 $50,540 - $131,740
7,000 Added 5.51%
134,030 $1 Million
Q1 2024

May 08, 2024

BUY
$16.79 - $25.38 $560,786 - $847,692
33,400 Added 35.67%
127,030 $2.17 Million
Q4 2023

Feb 12, 2024

BUY
$12.21 - $23.36 $1.14 Million - $2.19 Million
93,630 New
93,630 $2.13 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $54.3M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.